Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pritchard

Showing results (381-390 of 493) with videos related to

Pageof 50
Sort By:
Preventive Veterinary Medicine|June 22, 2007
Identification of management risk factors for VTEC O157 in young-stock in England and WalesJohanne Ellis-Iversen, Richard P Smith, Lucy C Snow, et al.
The Prostate|March 14, 2019
Clinical determinants for successful circulating tumor DNA analysis in prostate cancerMichael T Schweizer, Roman Gulati, Mallory Beightol, et al.
JCO Precision Oncology|June 17, 2024
Combined Germline and Mosaic SDHA Mutation Is Associated With a Multicancer Syndrome Including Neuroblastoma, Renal Cancer, and Multifocal GI TumorLee D Cranmer, Eric Q Konnick, Jennifer R Yoshida, et al.
The Journal of Molecular Diagnostics : JMD|May 13, 2014
Detection of gene rearrangements in targeted clinical next-generation sequencingHaley J Abel, Hussam Al-Kateb, Catherine E Cottrell, et al.
Journal of Veterinary Internal Medicine|May 3, 2025
Clinical Features That Increase Suspicion of Brucella canis Infection in Dogs With Discospondylitis: A Multicenter Case-Control StudyCourtney M Moeller, Joseph W Bartges, Kelsey D Brust, et al.
Bioorganic & Medicinal Chemistry|October 1, 1996
Cholecystokinin B antagonists. Synthesis and quantitative structure-activity relationships of a series of C-terminal analogues of CI-988C E Augelli-Szafran, D C Horwell, C Kneen, et al.
European Urology Oncology|May 24, 2025
Results from a Phase 2 Study of Induction Docetaxel and Carboplatin Followed by Maintenance Rucaparib in the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer with DNA Homologous Recombination Repair DeficiencyRuben Raychaudhuri, Heather H Cheng, Roman Gulati, et al.
The Prostate|September 30, 2016
Beyond Seed and Soil: Understanding and Targeting Metastatic Prostate Cancer; Report From the 2016 Coffey-Holden Prostate Cancer Academy MeetingAndrea K Miyahira, Sameek Roychowdhury, Sangeeta Goswami, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
PD 176252--the first high affinity non-peptide gastrin-releasing peptide (BB2) receptor antagonistV Ashwood, V Brownhill, M Higginbottom, et al.
Journal for Immunotherapy of Cancer|April 19, 2018
Microsatellite instability in prostate cancer by PCR or next-generation sequencingJennifer A Hempelmann, Christina M Lockwood, Eric Q Konnick, et al.
Pageof 50

Showing results (381-390 of 493) with videos related to

Sort By:
Pageof 50
Preventive Veterinary Medicine|June 22, 2007
Identification of management risk factors for VTEC O157 in young-stock in England and WalesJohanne Ellis-Iversen, Richard P Smith, Lucy C Snow, et al.
The Prostate|March 14, 2019
Clinical determinants for successful circulating tumor DNA analysis in prostate cancerMichael T Schweizer, Roman Gulati, Mallory Beightol, et al.
JCO Precision Oncology|June 17, 2024
Combined Germline and Mosaic SDHA Mutation Is Associated With a Multicancer Syndrome Including Neuroblastoma, Renal Cancer, and Multifocal GI TumorLee D Cranmer, Eric Q Konnick, Jennifer R Yoshida, et al.
The Journal of Molecular Diagnostics : JMD|May 13, 2014
Detection of gene rearrangements in targeted clinical next-generation sequencingHaley J Abel, Hussam Al-Kateb, Catherine E Cottrell, et al.
Journal of Veterinary Internal Medicine|May 3, 2025
Clinical Features That Increase Suspicion of Brucella canis Infection in Dogs With Discospondylitis: A Multicenter Case-Control StudyCourtney M Moeller, Joseph W Bartges, Kelsey D Brust, et al.
Bioorganic & Medicinal Chemistry|October 1, 1996
Cholecystokinin B antagonists. Synthesis and quantitative structure-activity relationships of a series of C-terminal analogues of CI-988C E Augelli-Szafran, D C Horwell, C Kneen, et al.
European Urology Oncology|May 24, 2025
Results from a Phase 2 Study of Induction Docetaxel and Carboplatin Followed by Maintenance Rucaparib in the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer with DNA Homologous Recombination Repair DeficiencyRuben Raychaudhuri, Heather H Cheng, Roman Gulati, et al.
The Prostate|September 30, 2016
Beyond Seed and Soil: Understanding and Targeting Metastatic Prostate Cancer; Report From the 2016 Coffey-Holden Prostate Cancer Academy MeetingAndrea K Miyahira, Sameek Roychowdhury, Sangeeta Goswami, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
PD 176252--the first high affinity non-peptide gastrin-releasing peptide (BB2) receptor antagonistV Ashwood, V Brownhill, M Higginbottom, et al.
Journal for Immunotherapy of Cancer|April 19, 2018
Microsatellite instability in prostate cancer by PCR or next-generation sequencingJennifer A Hempelmann, Christina M Lockwood, Eric Q Konnick, et al.
Pageof 50